Extensive studies indicate that FOXP4-AS1 is highly expressed in several malignancies, including hepatocellular carcinoma (12), colorectal carcinoma (13), and nasopharyngeal carcinoma (14). This evidence concerns the gene FOXP4 and nasopharyngeal carcinoma.